SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006701
Filing Date
2017-02-01
Accepted
2017-02-01 16:23:48
Documents
1
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4279
  Complete submission text file 0001209191-17-006701.txt   5817
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONATUS PHARMACEUTICALS INC. 16745 WEST BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127
Business Address
Smith Edward F III (Reporting) CIK: 0001670699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 17565202